Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics RMD OPEN Kremer, J. M., Schiff, M., Muram, D., Zhong, J., Alam, J., Genovese, M. C. 2018; 4 (1)
View details for DOI 10.1136/rmdopen-2017-000581
View details for Web of Science ID 000427250300009